Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$10.54 USD
-0.02 (-0.19%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $10.55 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
MD 10.54 -0.02(-0.19%)
Will MD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MD
Pediatrix Medical Group (MD)'s Technical Outlook is Bright After Key Golden Cross
Why Is Pediatrix Medical Group (MD) Up 9.5% Since Last Earnings Report?
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pediatrix Medical Group (MD) Shows Fast-paced Momentum But Is Still a Bargain Stock
MD or RVTY: Which Is the Better Value Stock Right Now?
All You Need to Know About Pediatrix Medical Group (MD) Rating Upgrade to Strong Buy
Other News for MD
Insider Sale: CEO James Swift Sells Shares of Pediatrix Medical Group Inc (MD)
Midland and SOQUEM Identify on Nachicapau New High-Grade Mineralized Occurrences and Expand the Footprint of the Copper-Gold-Silver Hydrothermal System
Key Takeaways From Pediatrix Medical Group Analyst Ratings
Pediatrix Medical price target raised by $2 at Truist, here's why
Insider Sale at Pediatrix Medical Group Inc (MD)